UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by HighPoint Advisor Group LLC

HighPoint Advisor Group LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 17.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 25,915 shares of the healthcare conglomerate's stock after selling 5,567 shares during the quarter. UnitedHealth Group accounts for 0.8% of HighPoint Advisor Group LLC's investment portfolio, making the stock its 24th largest holding. HighPoint Advisor Group LLC's holdings in UnitedHealth Group were worth $13,672,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Howard Capital Management Group LLC acquired a new stake in UnitedHealth Group in the third quarter valued at $341,000. Principal Financial Group Inc. boosted its holdings in UnitedHealth Group by 11.3% during the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock worth $1,039,933,000 after buying an additional 180,479 shares in the last quarter. Edgestream Partners L.P. purchased a new position in UnitedHealth Group in the third quarter valued at about $4,522,000. Cobblestone Capital Advisors LLC NY boosted its position in UnitedHealth Group by 1.0% during the third quarter. Cobblestone Capital Advisors LLC NY now owns 3,476 shares of the healthcare conglomerate's stock worth $2,032,000 after purchasing an additional 33 shares in the last quarter. Finally, Bellevue Group AG increased its position in shares of UnitedHealth Group by 9.7% in the third quarter. Bellevue Group AG now owns 225,550 shares of the healthcare conglomerate's stock valued at $131,875,000 after buying an additional 19,875 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Remove Ads

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Up 0.1 %

NYSE UNH traded up $0.49 on Wednesday, reaching $523.61. The company had a trading volume of 2,364,754 shares, compared to its average volume of 4,265,419. The firm has a 50-day moving average of $509.06 and a 200-day moving average of $542.96. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market capitalization of $478.95 billion, a PE ratio of 33.78, a P/E/G ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm's revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the prior year, the company posted $5.83 EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. UnitedHealth Group's dividend payout ratio (DPR) is 54.19%.

Analysts Set New Price Targets

Several equities analysts have weighed in on the stock. Piper Sandler dropped their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a report on Thursday, January 2nd. HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a research note on Friday, January 10th. Barclays cut their price target on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a report on Friday, January 17th. Hsbc Global Res raised shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Finally, KeyCorp reiterated an "overweight" rating and set a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group has an average rating of "Buy" and an average target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.